Page last updated: 2024-10-28

gyki 52466 and Magnesium Deficiency

gyki 52466 has been researched along with Magnesium Deficiency in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Magnesium Deficiency: A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (Harrison's Principles of Internal Medicine, 12th ed, p1936)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gulyás-Kovács, A1
Dóczi, J1
Tarnawa, I1
Détári, L1
Banczerowski-Pelyhe, I1
Világi, I1
Lasztóczi, B1
Kardos, J1

Other Studies

2 other studies available for gyki 52466 and Magnesium Deficiency

ArticleYear
Comparison of spontaneous and evoked epileptiform activity in three in vitro epilepsy models.
    Brain research, 2002, Aug-02, Volume: 945, Issue:2

    Topics: 2-Amino-5-phosphonovalerate; 4-Aminopyridine; Animals; Anti-Anxiety Agents; Benzodiazepines; Bicucul

2002
Cyclothiazide prolongs low [Mg2+]-induced seizure-like events.
    Journal of neurophysiology, 2006, Volume: 96, Issue:6

    Topics: 4-Aminopyridine; Animals; Benzodiazepines; Benzothiadiazines; Diuretics; Excitatory Amino Acid Antag

2006